Our Summary
This study is looking at the effectiveness of a specific type of sinus surgery, called endoscopic sinus surgery (ESS), in adults who repeatedly experience sinus infections. These infections can lead to numerous symptoms, the need for antibiotics, time off work, and a lower quality of life. ESS is believed to reduce these symptoms and improve quality of life by improving drainage in the sinuses. The study will compare a group of 80 adults undergoing ESS to a group receiving standard medical treatment to see which group shows more improvement in a quality of life questionnaire over a 6 month period. The results of this study will provide new information about the benefits and potential harms of ESS for adults with recurring sinus infections.
FAQs
- What is the purpose of the study on endoscopic sinus surgery (ESS)?
- How does ESS potentially improve the quality of life for adults with recurring sinus infections?
- How will the effectiveness of ESS be compared to standard medical treatments in the study?
Doctor’s Tip
One helpful tip a doctor might give a patient about sinus surgery is to follow all pre-operative and post-operative instructions carefully. This may include avoiding certain medications, preparing for any necessary dietary restrictions, and following proper wound care protocols. Additionally, it is important to attend all follow-up appointments and communicate any concerns or changes in symptoms to your healthcare provider. By following these instructions closely, patients can help ensure a successful and smooth recovery from sinus surgery.
Suitable For
Patients who are typically recommended sinus surgery are those who have chronic sinusitis that does not respond to other treatments such as antibiotics, nasal sprays, and allergy medications. These patients may experience symptoms such as facial pain or pressure, nasal congestion, headaches, and post-nasal drip. They may also have nasal polyps, a deviated septum, or other structural issues in the sinuses that contribute to their symptoms. Patients who have recurrent sinus infections, also known as acute sinusitis, may also be candidates for sinus surgery if their infections are not responding to other treatments.
Timeline
Before sinus surgery:
- Patient experiences recurring sinus infections, leading to symptoms such as facial pain, headache, congestion, and fatigue.
- Patient may be prescribed antibiotics and other medications to manage symptoms.
- Patient may require time off work or school due to the severity of symptoms.
- Quality of life may be significantly impacted by the frequency and intensity of sinus infections.
After sinus surgery:
- Patient undergoes endoscopic sinus surgery (ESS) to improve drainage in the sinuses.
- Recovery period typically involves some discomfort, swelling, and congestion as the sinuses heal.
- Over time, patient may experience a reduction in sinus infection symptoms and a decrease in the need for antibiotics.
- Quality of life may improve as symptoms decrease and the frequency of sinus infections decreases.
- Follow-up appointments with the surgeon may be necessary to monitor progress and address any concerns.
What to Ask Your Doctor
- What are the potential risks and complications associated with endoscopic sinus surgery?
- What is the success rate of endoscopic sinus surgery for patients with recurring sinus infections?
- How long is the recovery process after endoscopic sinus surgery?
- Will I need to take time off work or make any lifestyle changes after the surgery?
- Are there any alternative treatments or medications that I can try before considering surgery?
- How long will the effects of the surgery last? Will I need additional treatments in the future?
- Will I need any follow-up appointments or additional procedures after the surgery?
- How experienced is the surgeon in performing endoscopic sinus surgery?
- What can I expect in terms of pain management and post-operative care?
- How will I know if the surgery was successful in improving my symptoms and quality of life?
Reference
Authors: Kaski HM, Alakärppä A, Lantto U, Laajala A, Tokola P, Penna T, Ohtonen P, Alho OP. Journal: Trials. 2021 Sep 8;22(1):606. doi: 10.1186/s13063-021-05576-z. PMID: 34496924